127 related articles for article (PubMed ID: 38763984)
1. A de novo germline pathogenic BRCA1 variant identified following an osteosarcoma pangenomic molecular analysis.
Mouren A; Chansavang A; Hamzaoui N; Srikaran A; Laurent-Puig P; Marisa L; De Percin S; Lupo A; Larousserie F; Blons H; L'Haridon A; Burnichon N; Pasmant E; Tlemsani C
Fam Cancer; 2024 May; ():. PubMed ID: 38763984
[TBL] [Abstract][Full Text] [Related]
2. The multiple de novo copy number variant (MdnCNV) phenomenon presents with peri-zygotic DNA mutational signatures and multilocus pathogenic variation.
Du H; Jolly A; Grochowski CM; Yuan B; Dawood M; Jhangiani SN; Li H; Muzny D; Fatih JM; Coban-Akdemir Z; Carlin ME; Scheuerle AE; Witzl K; Posey JE; Pendleton M; Harrington E; Juul S; Hastings PJ; Bi W; Gibbs RA; Sedlazeck FJ; Lupski JR; Carvalho CMB; Liu P
Genome Med; 2022 Oct; 14(1):122. PubMed ID: 36303224
[TBL] [Abstract][Full Text] [Related]
3. Inherited BRCA1 and RNF43 pathogenic variants in a familial colorectal cancer type X family.
Chan JM; Clendenning M; Joseland S; Georgeson P; Mahmood K; Joo JE; Walker R; Como J; Preston S; Chai SM; Chu YL; Meyers AL; Pope BJ; Duggan D; Fink JL; Macrae FA; Rosty C; Winship IM; Jenkins MA; Buchanan DD
Fam Cancer; 2024 Mar; 23(1):9-21. PubMed ID: 38063999
[TBL] [Abstract][Full Text] [Related]
4. Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers.
Nones K; Johnson J; Newell F; Patch AM; Thorne H; Kazakoff SH; de Luca XM; Parsons MT; Ferguson K; Reid LE; McCart Reed AE; Srihari S; Lakis V; Davidson AL; Mukhopadhyay P; Holmes O; Xu Q; Wood S; Leonard C; ; ; ; Beesley J; Harris JM; Barnes D; Degasperi A; Ragan MA; Spurdle AB; Khanna KK; Lakhani SR; Pearson JV; Nik-Zainal S; Chenevix-Trench G; Waddell N; Simpson PT
Ann Oncol; 2019 Jul; 30(7):1071-1079. PubMed ID: 31090900
[TBL] [Abstract][Full Text] [Related]
5. Case Review: Whole-Exome Sequencing Analyses Identify Carriers of a Known Likely Pathogenic Intronic
Alenezi WM; Fierheller CT; Revil T; Serruya C; Mes-Masson AM; Foulkes WD; Provencher D; El Haffaf Z; Ragoussis J; Tonin PN
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456503
[TBL] [Abstract][Full Text] [Related]
6. Nearly Half of
Diessner BJ; Pankratz N; Hooten AJ; Mirabello L; Sarver AL; Mills LJ; Malkin D; Kelley AC; Spector LG
JCO Precis Oncol; 2020; 4():. PubMed ID: 33163847
[TBL] [Abstract][Full Text] [Related]
7. Biallelic
Wineland D; Le AN; Hausler R; Kelly G; Barrett E; Desai H; Wubbenhorst B; Pluta J; Bastian P; Symecko H; D'Andrea K; Doucette A; Gabriel P; Reiss KA; Nayak A; Feldman M; Domchek SM; Nathanson KL; Maxwell KN; ;
JCO Precis Oncol; 2023 Aug; 7():e2300036. PubMed ID: 37535879
[TBL] [Abstract][Full Text] [Related]
8. A de Novo BRCA1 Pathogenic Variant in a 29-Year-Old Woman with Triple-Negative Breast Cancer.
Gebhart P; Tan Y; Muhr D; Stein C; Singer C
Breast Care (Basel); 2023 Oct; 18(5):412-416. PubMed ID: 37901051
[TBL] [Abstract][Full Text] [Related]
9. A New de novo
Scherz A; Stoll S; Rothlisberger B; Rabaglio M
Appl Clin Genet; 2023; 16():83-87. PubMed ID: 37197323
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR study.
Cheng HF; Tsai YF; Liu CY; Hsu CY; Lien PJ; Lin YS; Chao TC; Lai JI; Feng CJ; Chen YJ; Chen BF; Chiu JH; Tseng LM; Huang CC
Breast Cancer Res; 2023 Dec; 25(1):152. PubMed ID: 38098088
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma.
Johansson PA; Nathan V; Bourke LM; Palmer JM; Zhang T; Symmons J; Howlie M; Patch AM; Read J; Holland EA; Schmid H; Warrier S; Glasson W; Höiom V; Wadt K; Jönsson G; Olsson H; Ingvar C; Mann G; Brown KM; Hayward NK; Pritchard AL
Melanoma Res; 2019 Oct; 29(5):483-490. PubMed ID: 31464824
[TBL] [Abstract][Full Text] [Related]
12. Hereditary cancer variants and homologous recombination deficiency in biliary tract cancer.
Okawa Y; Iwasaki Y; Johnson TA; Ebata N; Inai C; Endo M; Maejima K; Sasagawa S; Fujita M; Matsuda K; Murakami Y; Nakamura T; Hirano S; Momozawa Y; Nakagawa H
J Hepatol; 2023 Feb; 78(2):333-342. PubMed ID: 36243179
[TBL] [Abstract][Full Text] [Related]
13. Low-level constitutional mosaicism of BRCA1 in two women with young onset ovarian cancer.
Speight B; Colvin E; Epurescu ED; Drummond J; Verhoef S; Pereira M; Evans DG; Tischkowitz M
Hered Cancer Clin Pract; 2022 Sep; 20(1):32. PubMed ID: 36068545
[TBL] [Abstract][Full Text] [Related]
14. Case Report Series: Aggressive HR Deficient Colorectal Cancers Related to BRCA1 Pathogenic Germline Variants.
Freire MV; Martin M; Thissen R; Van Marcke C; Segers K; Sépulchre E; Leroi N; Lété C; Fasquelle C; Radermacher J; Gokburun Y; Collignon J; Sacré A; Josse C; Palmeira L; Bours V
Front Oncol; 2022; 12():835581. PubMed ID: 35280729
[TBL] [Abstract][Full Text] [Related]
15. Endometrial Cancers in
Smith ES; Da Cruz Paula A; Cadoo KA; Abu-Rustum NR; Pei X; Brown DN; Ferrando L; Sebastiao APM; Riaz N; Robson ME; Soslow RA; Reis-Filho JS; Mandelker D; Weigelt B
JCO Precis Oncol; 2019; 3():. PubMed ID: 32914019
[TBL] [Abstract][Full Text] [Related]
16. Preclinical workup using long-read amplicon sequencing provides families with de novo pathogenic variants access to universal preimplantation genetic testing.
Tsuiko O; El Ayeb Y; Jatsenko T; Allemeersch J; Melotte C; Ding J; Debrock S; Peeraer K; Vanhie A; De Leener A; Pirard C; Kluyskens C; Denayer E; Legius E; Vermeesch JR; Brems H; Dimitriadou E
Hum Reprod; 2023 Mar; 38(3):511-519. PubMed ID: 36625546
[TBL] [Abstract][Full Text] [Related]
17. De novo germline pathogenic variant in Lynch Syndrome: A rare event or the tip of the iceberg?
Brignola C; Volorio S; De Vecchi G; Zaffaroni D; Dall'Olio V; Mariette F; Sardella D; Capra F; Signoroni S; Rausa E; Vitellaro M; Pensotti V; Ricci MT
Tumori; 2024 Feb; 110(1):69-73. PubMed ID: 37691472
[TBL] [Abstract][Full Text] [Related]
18. Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families.
Van Marcke C; Helaers R; De Leener A; Merhi A; Schoonjans CA; Ambroise J; Galant C; Delrée P; Rothé F; Bar I; Khoury E; Brouillard P; Canon JL; Vuylsteke P; Machiels JP; Berlière M; Limaye N; Vikkula M; Duhoux FP
Breast Cancer Res; 2020 Apr; 22(1):36. PubMed ID: 32295625
[TBL] [Abstract][Full Text] [Related]
19. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.
Mirabello L; Zhu B; Koster R; Karlins E; Dean M; Yeager M; Gianferante M; Spector LG; Morton LM; Karyadi D; Robison LL; Armstrong GT; Bhatia S; Song L; Pankratz N; Pinheiro M; Gastier-Foster JM; Gorlick R; de Toledo SRC; Petrilli AS; Patino-Garcia A; Lecanda F; Gutierrez-Jimeno M; Serra M; Hattinger C; Picci P; Scotlandi K; Flanagan AM; Tirabosco R; Amary MF; Kurucu N; Ilhan IE; Ballinger ML; Thomas DM; Barkauskas DA; Mejia-Baltodano G; Valverde P; Hicks BD; Zhu B; Wang M; Hutchinson AA; Tucker M; Sampson J; Landi MT; Freedman ND; Gapstur S; Carter B; Hoover RN; Chanock SJ; Savage SA
JAMA Oncol; 2020 May; 6(5):724-734. PubMed ID: 32191290
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
